A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
Jeremy Corbyn has challenged Theresa May to better fund the police and fire services by backing a Labour amendment to the Queen's Speech.
All 33 London councils were warned about "combustible" panels being used on buildings which could potentially spread blazes.
It happened at a rail depot near Daventry in Northamptonshire.